4.5 Article

Application of Novel Breast Biospecimen Cell-Type Adjustment Identifies Shared DNA Methylation Alterations in Breast Tissue and Milk with Breast Cancer- Risk Factors

期刊

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
卷 32, 期 4, 页码 550-560

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-22-0405

关键词

-

向作者/读者索取更多资源

DNA methylation is cell-type-specific and altered DNA methylation is established to occur early in breast carcinogenesis. This study presents a novel method for estimating the cellular composition of breast tissue and milk and assessing cell-type-independent alterations to DNA methylation associated with breast cancer risk factors. The study identified age-associated hypermethylated CpGs in both breast tissue and breast milk.
Background: DNA methylation patterning is cell-type-specific and altered DNA methylation is well established to occur early in breast carcinogenesis, affecting non-cancerous, histopathologically normal breast tissue. Previous work assessing risk factor-associated alterations to DNA methylation in breast tissue has been limited, with even less published research in breast milk, a noninvasively obtained biospecimen containing sloughed mammary epithelial cells that may identify early alterations indicative of cancer risk. Methods: Here, we present a novel library for the estimation of the cellular composition of breast tissue and milk and subsequent assessment of cell-type-independent alterations to DNA methyla-tion associated with established breast cancer-risk factors in solid breast tissue (n = 95) and breast milk (n = 48) samples using genome-scale DNA methylation measures from the Illumina HumanMethylation450 array. Results: We identified 772 hypermethylated CpGs (P < 0.01) associated with age consistent between breast tissue and breast milk samples. Age-associated hypermethylated CpG loci were signifi- cantly enriched for CpG island shore regions known to be important for regulating gene expression. Among the overlapping hyper-methylated loci mapping to genes, a differentially methylated region was identified in the promoter region of SFRP2, a gene observed to undergo promoter hypermethylation in breast cancer. Conclusions: Our findings suggest the potential to identify epigenetic biomarkers of breast cancer risk in noninvasively obtained, tissue-specific breast milk specimens. Impact: This work demonstrates the potential of using breast milk as a noninvasive biomarker of breast cancer risk, improving our ability to detect early-stage disease and lowering the overall disease burden.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据